Jan Patrick Oscar Schuemann, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Monte Carlo Method | 55 | 2024 | 1257 | 6.400 |
Why?
|
Protons | 22 | 2023 | 1114 | 4.010 |
Why?
|
Metal Nanoparticles | 13 | 2021 | 399 | 3.590 |
Why?
|
Gold | 12 | 2021 | 484 | 2.980 |
Why?
|
Radiobiology | 9 | 2024 | 89 | 2.560 |
Why?
|
Radiotherapy Dosage | 25 | 2024 | 2897 | 2.300 |
Why?
|
Radiation-Sensitizing Agents | 7 | 2019 | 345 | 2.280 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 16 | 2024 | 1660 | 2.110 |
Why?
|
DNA Damage | 14 | 2023 | 2442 | 1.850 |
Why?
|
Computer Simulation | 21 | 2024 | 6218 | 1.530 |
Why?
|
Photons | 8 | 2024 | 581 | 1.510 |
Why?
|
Linear Energy Transfer | 14 | 2023 | 152 | 1.360 |
Why?
|
Radiation Dosage | 8 | 2024 | 1958 | 1.290 |
Why?
|
Radiometry | 10 | 2024 | 813 | 1.200 |
Why?
|
DNA | 9 | 2024 | 7233 | 0.970 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2024 | 881 | 0.840 |
Why?
|
Models, Biological | 7 | 2024 | 9467 | 0.830 |
Why?
|
Alpha Particles | 2 | 2021 | 29 | 0.820 |
Why?
|
Electrons | 8 | 2023 | 264 | 0.810 |
Why?
|
Relative Biological Effectiveness | 9 | 2019 | 312 | 0.810 |
Why?
|
Yttrium Radioisotopes | 2 | 2024 | 107 | 0.790 |
Why?
|
Phantoms, Imaging | 11 | 2024 | 2512 | 0.770 |
Why?
|
Radiotherapy | 5 | 2024 | 1504 | 0.680 |
Why?
|
Water | 9 | 2023 | 1407 | 0.640 |
Why?
|
Algorithms | 12 | 2024 | 13981 | 0.580 |
Why?
|
Cell Physiological Phenomena | 1 | 2018 | 150 | 0.570 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1433 | 0.520 |
Why?
|
Radiation Tolerance | 5 | 2023 | 480 | 0.450 |
Why?
|
DNA Repair | 5 | 2023 | 2039 | 0.450 |
Why?
|
Radiation, Ionizing | 3 | 2022 | 251 | 0.410 |
Why?
|
DNA Breaks, Double-Stranded | 5 | 2024 | 607 | 0.390 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4319 | 0.370 |
Why?
|
Radiosurgery | 2 | 2019 | 1343 | 0.370 |
Why?
|
Software | 2 | 2023 | 4419 | 0.370 |
Why?
|
Blood Vessels | 1 | 2015 | 1112 | 0.340 |
Why?
|
Uncertainty | 6 | 2021 | 754 | 0.330 |
Why?
|
Neoplasms | 11 | 2024 | 22072 | 0.320 |
Why?
|
Necrosis | 2 | 2024 | 1612 | 0.310 |
Why?
|
Oxygen | 3 | 2024 | 4193 | 0.300 |
Why?
|
Acute Lung Injury | 1 | 2021 | 367 | 0.280 |
Why?
|
Neoplasms, Radiation-Induced | 3 | 2024 | 547 | 0.280 |
Why?
|
X-Rays | 4 | 2021 | 307 | 0.270 |
Why?
|
Neutrons | 2 | 2024 | 77 | 0.270 |
Why?
|
Nanostructures | 1 | 2021 | 547 | 0.260 |
Why?
|
Gamma Rays | 2 | 2024 | 317 | 0.260 |
Why?
|
Particle Size | 3 | 2021 | 1644 | 0.260 |
Why?
|
Models, Theoretical | 4 | 2019 | 3562 | 0.250 |
Why?
|
Cell Survival | 8 | 2022 | 5797 | 0.250 |
Why?
|
Arteriovenous Malformations | 2 | 2019 | 397 | 0.250 |
Why?
|
Boron Neutron Capture Therapy | 1 | 2024 | 50 | 0.240 |
Why?
|
Mathematical Concepts | 1 | 2024 | 73 | 0.240 |
Why?
|
Head and Neck Neoplasms | 3 | 2024 | 2882 | 0.230 |
Why?
|
Synchrotrons | 1 | 2023 | 39 | 0.220 |
Why?
|
Particle Accelerators | 1 | 2024 | 174 | 0.220 |
Why?
|
Humans | 57 | 2024 | 760621 | 0.220 |
Why?
|
Cosmic Radiation | 1 | 2022 | 20 | 0.210 |
Why?
|
Credentialing | 1 | 2023 | 115 | 0.210 |
Why?
|
Nanoparticles | 2 | 2024 | 1943 | 0.200 |
Why?
|
Lithium | 1 | 2024 | 596 | 0.190 |
Why?
|
Dimethyl Sulfoxide | 1 | 2021 | 252 | 0.180 |
Why?
|
Lymphopenia | 1 | 2023 | 280 | 0.180 |
Why?
|
Animals | 14 | 2024 | 167963 | 0.170 |
Why?
|
Stochastic Processes | 2 | 2020 | 354 | 0.170 |
Why?
|
Hydrogen Peroxide | 1 | 2023 | 732 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20509 | 0.170 |
Why?
|
Cell Nucleus | 2 | 2020 | 2907 | 0.170 |
Why?
|
Microtechnology | 1 | 2019 | 70 | 0.160 |
Why?
|
Pulse Radiolysis | 1 | 2018 | 6 | 0.160 |
Why?
|
Rib Fractures | 1 | 2020 | 128 | 0.160 |
Why?
|
Microspheres | 1 | 2021 | 787 | 0.160 |
Why?
|
Carbon Radioisotopes | 1 | 2019 | 557 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.150 |
Why?
|
Scattering, Radiation | 3 | 2017 | 488 | 0.150 |
Why?
|
Nucleic Acid Conformation | 2 | 2021 | 899 | 0.150 |
Why?
|
Biological Transport | 2 | 2019 | 2086 | 0.140 |
Why?
|
Peritoneal Neoplasms | 1 | 2023 | 707 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2024 | 1183 | 0.140 |
Why?
|
Computer Graphics | 1 | 2019 | 341 | 0.140 |
Why?
|
Hyperthermia, Induced | 1 | 2020 | 417 | 0.140 |
Why?
|
Brachytherapy | 1 | 2024 | 1238 | 0.140 |
Why?
|
Chromosome Aberrations | 2 | 2020 | 1764 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2773 | 0.130 |
Why?
|
Blood Circulation Time | 1 | 2015 | 10 | 0.130 |
Why?
|
Organs at Risk | 2 | 2015 | 358 | 0.130 |
Why?
|
Plasmids | 2 | 2021 | 2275 | 0.130 |
Why?
|
Diagnostic Imaging | 2 | 2021 | 3527 | 0.130 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2015 | 276 | 0.120 |
Why?
|
Radiation Monitoring | 1 | 2015 | 103 | 0.120 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2640 | 0.120 |
Why?
|
DNA Replication | 1 | 2021 | 1412 | 0.110 |
Why?
|
Carbon | 1 | 2017 | 669 | 0.110 |
Why?
|
Drug Carriers | 2 | 2024 | 709 | 0.110 |
Why?
|
Cytosol | 1 | 2016 | 887 | 0.110 |
Why?
|
Prostate | 1 | 2021 | 1793 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1728 | 0.110 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20080 | 0.100 |
Why?
|
Neuroma, Acoustic | 1 | 2016 | 459 | 0.100 |
Why?
|
Surface Properties | 1 | 2015 | 1161 | 0.100 |
Why?
|
User-Computer Interface | 1 | 2019 | 1403 | 0.100 |
Why?
|
Mice | 6 | 2024 | 81208 | 0.100 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3844 | 0.100 |
Why?
|
Rectum | 1 | 2015 | 895 | 0.090 |
Why?
|
Fibroblasts | 1 | 2020 | 4090 | 0.090 |
Why?
|
Probability | 1 | 2015 | 2475 | 0.080 |
Why?
|
Organ Specificity | 1 | 2014 | 1955 | 0.080 |
Why?
|
Brain Neoplasms | 2 | 2024 | 8986 | 0.080 |
Why?
|
Skin | 1 | 2023 | 4466 | 0.080 |
Why?
|
Urinary Bladder | 1 | 2015 | 1166 | 0.080 |
Why?
|
Simvastatin | 1 | 2021 | 352 | 0.080 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22023 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2016 | 1313 | 0.080 |
Why?
|
Meningioma | 1 | 2016 | 1221 | 0.070 |
Why?
|
Meningeal Neoplasms | 1 | 2016 | 1249 | 0.070 |
Why?
|
Cell Line, Tumor | 5 | 2024 | 16939 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4878 | 0.070 |
Why?
|
Models, Molecular | 1 | 2016 | 5434 | 0.070 |
Why?
|
Adenoma | 1 | 2016 | 2148 | 0.070 |
Why?
|
Cricetinae | 2 | 2022 | 2427 | 0.060 |
Why?
|
Lutetium | 1 | 2023 | 34 | 0.060 |
Why?
|
Radioimmunotherapy | 1 | 2023 | 91 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13262 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10827 | 0.050 |
Why?
|
Mitochondria | 1 | 2016 | 3600 | 0.050 |
Why?
|
Radioisotopes | 1 | 2023 | 495 | 0.050 |
Why?
|
Elasticity | 1 | 2024 | 652 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 2020 | 21025 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2019 | 6131 | 0.050 |
Why?
|
Sulfuric Acids | 1 | 2020 | 36 | 0.050 |
Why?
|
Cobalt Radioisotopes | 1 | 2020 | 75 | 0.050 |
Why?
|
Ferrous Compounds | 1 | 2020 | 41 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 13630 | 0.050 |
Why?
|
Female | 11 | 2024 | 391270 | 0.050 |
Why?
|
Technology | 1 | 2023 | 291 | 0.050 |
Why?
|
Patient Positioning | 1 | 2023 | 327 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2024 | 961 | 0.040 |
Why?
|
Time Factors | 3 | 2024 | 40165 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2022 | 80372 | 0.040 |
Why?
|
Lipids | 1 | 2021 | 3336 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2023 | 2262 | 0.040 |
Why?
|
Dogs | 1 | 2024 | 3841 | 0.040 |
Why?
|
Brain | 3 | 2024 | 26951 | 0.040 |
Why?
|
Nanotechnology | 1 | 2024 | 709 | 0.040 |
Why?
|
Gadolinium | 1 | 2023 | 959 | 0.040 |
Why?
|
Oligopeptides | 1 | 2024 | 1187 | 0.040 |
Why?
|
Chemical Phenomena | 1 | 2018 | 508 | 0.040 |
Why?
|
Health Facilities | 1 | 2023 | 578 | 0.040 |
Why?
|
Models, Statistical | 3 | 2019 | 5075 | 0.040 |
Why?
|
Endpoint Determination | 1 | 2020 | 597 | 0.040 |
Why?
|
Male | 7 | 2024 | 359744 | 0.040 |
Why?
|
Plastics | 1 | 2017 | 115 | 0.040 |
Why?
|
Quality Control | 1 | 2020 | 828 | 0.040 |
Why?
|
ROC Curve | 1 | 2024 | 3568 | 0.030 |
Why?
|
Ions | 1 | 2017 | 261 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2024 | 2326 | 0.030 |
Why?
|
Tomography | 1 | 2018 | 411 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2020 | 2502 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 2 | 2020 | 4048 | 0.030 |
Why?
|
Temperature | 1 | 2022 | 2221 | 0.030 |
Why?
|
Drug Synergism | 1 | 2019 | 1754 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 816 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6377 | 0.030 |
Why?
|
Lymphocytes | 1 | 2023 | 2611 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2016 | 736 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3484 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3105 | 0.030 |
Why?
|
Cricetulus | 1 | 2015 | 815 | 0.030 |
Why?
|
Sarcoma | 1 | 2024 | 1786 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11345 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 15620 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 6965 | 0.020 |
Why?
|
Respiration | 1 | 2014 | 1654 | 0.020 |
Why?
|
Movement | 1 | 2014 | 1474 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2019 | 2003 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36290 | 0.020 |
Why?
|
Cell Communication | 1 | 2012 | 1653 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10446 | 0.020 |
Why?
|
Mutation | 2 | 2021 | 29932 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8056 | 0.010 |
Why?
|
Neurons | 1 | 2022 | 9426 | 0.010 |
Why?
|
Adult | 3 | 2024 | 219994 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24123 | 0.010 |
Why?
|
Aged | 2 | 2024 | 169152 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 220352 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58995 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36060 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 42063 | 0.010 |
Why?
|
Adolescent | 1 | 2015 | 87810 | 0.000 |
Why?
|